Brain oxygen dips linked to injury markers in severe TBI
NCT ID NCT04565119
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study looks at 300 adults with severe traumatic brain injury to see how low brain oxygen levels affect certain proteins in the blood, known as biomarkers. Researchers will measure these proteins to better understand brain damage and recovery. The study does not test any new treatment but aims to improve knowledge for future care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand how low oxygen levels in the brain after injury affect recovery, potentially leading to improved monitoring and treatment strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new therapy, and the findings may not lead to immediate changes in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2020
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The investigators plan to enroll a maximum of 300 male and female subjects among multiple clinical sites.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Enrolled in BOOST-3 (this is an ancillary study to the BOOST-3 trial) * BOOST-3 participant is enrolled at a BioBOOST site * Able to maintain initial blood sample within 24 hours of injury * Provide proxy informed consent Exclusion Criteria: * Profoundly anemic (subjects who are profoundly anemic require blood transfusion) * Age less than 18 years
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TBI (traumatic brain injury) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New score aims to flag deadliest brain injuries
- Which works faster: saline or mannitol for brain swelling?
- Brain injury and mental exhaustion: a new test on the horizon?
- Zapping the brain back to life: could DBS reawaken cognition after severe head trauma?
- Zapping a nerve in the neck may help rewire the brain after traumatic injury
- Rhythmic sound may retrain the brain to walk better after TBI